Ultragenyx Pharmaceutical Cash from Operations (TTM) Insights

Ultragenyx Pharmaceutical Inc (RARE)

43.85 -0.43 (-0.97%) USD | NASDAQ | Apr 25, 16:00

43.85 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-474.81M
September 30, 2023	-481.24M
June 30, 2023	-458.72M
March 31, 2023	-419.81M
December 31, 2022	-380.46M
September 30, 2022	-344.47M
June 30, 2022	-308.77M
March 31, 2022	-296.87M
December 31, 2021	-338.70M
September 30, 2021	-346.80M
June 30, 2021	-349.12M
March 31, 2021	-196.41M
December 31, 2020	-132.22M
September 30, 2020	-141.81M
June 30, 2020	-168.35M
March 31, 2020	-344.76M
December 31, 2019	-345.38M
September 30, 2019	-329.20M
June 30, 2019	-309.85M
March 31, 2019	-296.86M
December 31, 2018	-290.57M

Date	Value
September 30, 2018	-316.54M
June 30, 2018	-309.37M
March 31, 2018	-282.12M
December 31, 2017	-253.84M
September 30, 2017	-219.70M
June 30, 2017	-186.45M
March 31, 2017	-177.28M
December 31, 2016	-160.98M
September 30, 2016	-153.74M
June 30, 2016	-155.60M
March 31, 2016	-133.21M
December 31, 2015	-105.98M
September 30, 2015	-77.99M
June 30, 2015	-58.42M
March 31, 2015	-51.67M
December 31, 2014	-44.63M
September 30, 2014	-41.95M
June 30, 2014	-37.67M
March 31, 2014	-35.53M
December 31, 2013	-31.20M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-481.24M

Minimum

Sep 2023

-132.22M

Maximum

Dec 2020

-324.62M

Average

-344.47M

Median

Sep 2022

Cash from Operations (TTM) Benchmarks